Strategies Used by Hospitals to Improve Speed of Tissue-Type Plasminogen Activator Treatment in Acute Ischemic Stroke | Zendy

Ying Xian | Zendy; Eric E. Smith | Zendy; Xin Zhao | Zendy; Eric D. Peterson | Zendy; DaiWai M. Olson | Zendy; Adrian F. Hernandez | Zendy; Deepak L. Bhatt | Zendy; Jeffrey L. Saver | Zendy; Lee H. Schwamm | Zendy; Gregg C. Fonarow | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Strategies Used by Hospitals to Improve Speed of Tissue-Type Plasminogen Activator Treatment in Acute Ischemic Stroke

Author(s) -

Ying Xian,

Eric E. Smith,

Xin Zhao,

Eric D. Peterson,

DaiWai M. Olson,

Adrian F. Hernandez,

Deepak L. Bhatt,

Jeffrey L. Saver,

Lee H. Schwamm,

Gregg C. Fonarow

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.003898

Subject(s) - medicine , tissue plasminogen activator , plasminogen activator , ischemic stroke , stroke (engine) , thrombolysis , fibrinolytic agent , cardiology , brain ischemia , intensive care medicine , ischemia , myocardial infarction , mechanical engineering , engineering

The benefits of intravenous tissue-type plasminogen activator in acute ischemic stroke are time dependent, and several strategies have been reported to be associated with more rapid door-to-needle (DTN) times. However, the extent to which hospitals are using these strategies and their association with DTN times have not been well studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research